Tuberculosis Management in Developing Countries

Tuberculosis (TB) remains a significant global health challenge, particularly in developing countries where the burden is most pronounced. This chapter provides a concise overview of the epidemiology, challenges, and management strategies related to TB in these regions. TB prevalence in developing countries is disproportionately high due to factors such as limited healthcare infrastructure, diagnostic delays, high rates of HIV-TB co-infection, and drug-resistant TB. These challenges necessitate a comprehensive approach to TB management that includes strengthening healthcare systems, expanding access to TB services, early detection and diagnosis, and treatment adherence support. The integration of TB and HIV services, community engagement, and prevention strategies are also crucial components of TB control efforts in these regions. Furthermore, the management of TB in developing countries requires cross-sectoral collaboration, as addressing the social determinants of TB and ensuring continuity of care during emergencies are paramount. Advocacy for increased funding, political commitment, and international collaboration are essential to achieving these goals. Despite the formidable challenges, significant progress has been made in TB control efforts in developing countries. The implementation of recommendations, innovations in digital health, and the dedication of healthcare providers and communities are contributing to improved TB outcomes. Continued commitment and collaboration are essential to further reduce the TB burden and move closer to the global goal of ending TB as a public health threat.